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Brucellosis, an infectious disease caused by Brucella, is one of the most extended
bacterial zoonosis in the world and an important cause of economic losses and
human suffering. The lipopolysaccharide (LPS) of Brucella plays a major role in
virulence as it impairs normal recognition by the innate immune system and delays
the immune response. The LPS core is a branched structure involved in resistance
to complement and polycationic peptides, and mutants in glycosyltransferases required
for the synthesis of the lateral branch not linked to the O-polysaccharide (O-PS) are
attenuated and have been proposed as vaccine candidates. For this reason, the
complete understanding of the genes involved in the synthesis of this LPS section
is of particular interest. The chemical structure of the Brucella LPS core suggests
that, in addition to the already identified WadB and WadC glycosyltransferases, others
could be implicated in the synthesis of this lateral branch. To clarify this point, we
identified and constructed mutants in 11 ORFs encoding putative glycosyltransferases
in B. abortus. Four of these ORFs, regulated by the virulence regulator MucR (involved
in LPS synthesis) or the BvrR/BvrS system (implicated in the synthesis of surface
components), were not required for the synthesis of a complete LPS neither for virulence
or interaction with polycationic peptides and/or complement. Among the other seven
ORFs, six seemed not to be required for the synthesis of the core LPS since the
corresponding mutants kept the O-PS and reacted as the wild type with polyclonal
sera. Interestingly, mutant in ORF BAB1_0953 (renamed wadD) lost reactivity against
antibodies that recognize the core section while kept the O-PS. This suggests that
WadD is a new glycosyltransferase adding one or more sugars to the core lateral
branch. WadD mutants were more sensitive than the parental strain to components
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of the innate immune system and played a role in chronic stages of infection. These
results corroborate and extend previous work indicating that the Brucella LPS core is a
branched structure that constitutes a steric impairment preventing the elements of the
innate immune system to fight against Brucella.
Keywords: lipopolysaccharide (LPS), bacterial pathogenesis, vaccine development, virulence factor,
glycosyltransferase, brucellosis, Brucella
INTRODUCTION
Members of the genus Brucella are the etiologic agents of
brucellosis, a worldwide spread zoonosis that affects ruminants,
camelids, swine, dogs, and several forms of marine and
terrestrial wildlife and causes abortions, infertility, and the
subsequent economic losses in livestock. Humans become
infected via direct contact with affected animals and through
consumption of unpasteurized dairy products, and develop
a chronic and debilitating condition that requires prolonged
antibiotic treatment, being lethal in 1–5% of untreated cases
(Ariza, 1999). Because of its impact on animal production
and Public Health, it is estimated that brucellosis imposes
a heavy burden in the developing world (McDermott et al.,
2013).
The genus includes several nominal species that show
host preferences1. Those that have been known for a long
time (often referred to as “classical” Brucella species) include
B. abortus and B. melitensis (the brucellae that infect domestic
ruminants), B. suis (infecting swine, reindeer, hares, and several
species of wild rodents), B. canis (infecting dogs), B. ovis (not
zoonotic and restricted to sheep), and B. neotomae (infecting
the desert woodrat). Because of their early identification and
their economic and public health importance, B. abortus,
B. melitensis, and B. suis are the best-characterized members of
the genus, and all of them produce smooth (S) glossy colonies,
a morphology that reflects the existence of a lipopolysaccharide
(LPS) carrying an O-polysaccharide (O-PS) linked to the core-
lipid A section that anchors the molecule to the outer membrane
(OM). These Brucella spp. behave as facultative intracellular
parasites of professional and non-professional phagocytes, an
ability that depends on a number of virulence factors, chiefly
a type IV secretion system and a peculiar OM structure.
Critical OM components such as the S-LPS, lipoproteins,
and ornithine lipids differ in relevant molecular details from
the homologous molecules that in other bacteria bear the
pathogen-associated molecular patterns (PAMP) readily detected
by innate immunity pattern recognition receptors (PRRs).
Consequently, these brucellae induce comparatively low and
delayed proinflammatory responses, which create a time window
allowing the pathogen to traffic intracellularly in dendritic cells
and macrophages to reach a safe niche before effective phagocyte
activation takes place (Lapaque et al., 2005; Barquero-Calvo
et al., 2007; Palacios-Chaves et al., 2011). In this regard, the
Brucella S-LPS carries the most significant PAMP modifications
and is thus a major virulence factor (Lapaque et al., 2005).
1http://www.bacterio.net/-allnamesac.html
Whereas the structure of the O-PS (a N-formylperosamine
homopolymer) and its role in virulence in animal models and
in the natural host have been known for a long time, the
importance of the core and its structure have only recently been
established.
The core of B. melitensis LPS (Figure 1) is a branched
oligosaccharide built of lipid A-linked 3-deoxy-D-manno-2-
octulosonic acid (Kdo), glucose, 2-amino-2,6-dideoxy-D-glucose
(quinovosamine), mannose, and 2-amino-2-deoxy-D-glucose
[glucosamine (GlcN)] (Iriarte et al., 2004; Conde-Álvarez et al.,
2012; Kubler-Kielb and Vinogradov, 2013; Gil-Ramírez et al.,
2014; Fontana et al., 2016). This structure accounts for the
Brucella LPS core overlapping epitopes (Rojas et al., 1994) an
inner one comprising the Kdo residues plus the glucose bridging
KdoII with the O-PS and an outer epitope encompassing the
mannose and GlcN residues (Iriarte et al., 2004; González et al.,
2008; Fontana et al., 2016). This last epitope plays a critical
role in the binding of monoclonal antibodies (MoAbs) such
as A68/24G12/A08 and A08/24D08/G09 (Conde-Álvarez et al.,
2012; Fontana et al., 2016).
Accordingly, the reactivity with R-LPS-specific MoAbs
strongly suggests that the structure elucidated for B. melitensis is
conserved in the classical species (Bowden et al., 1995; Zygmunt
et al., 2012). Moreover, availability of the corresponding structure
of several mutants has also allowed assigning genes that upon
mutation generate LPSs that lack [i.e., rough (R) LPS] or
carry O-PS (Figure 1). Gene wadA corresponds to the enzyme
linking KdoII and glucose, wadC to the mannosyltransferase
acting on KdoI, and wadB to a glucosaminyltransferase involved
in the assembly of the GlcN branch (González et al., 2008;
Conde-Álvarez et al., 2012; Gil-Ramírez et al., 2014). These
genes are highly conserved in the classical Brucella species
(Monreal et al., 2003; Iriarte et al., 2004; González et al.,
2008; Conde-Álvarez et al., 2012; Gil-Ramírez et al., 2014;
Soler-Lloréns et al., 2016) and as expected, all Brucella
genomes also carry a waaA homolog, the essential gene
coding for the Kdo transferase of Gram-negative bacteria
(Raetz and Whitfield, 2002; Iriarte et al., 2004). However,
since most but not all glycosyltransferases involved in LPS
synthesis are monofunctional (Raetz and Whitfield, 2002), it
remains to be determined whether glucosaminyltransferases
other than WadB are required for the synthesis of the GlcN
branch.
Based on the complete structure of the core and the phenotype
of mutants in wadB and wadC, it is postulated that the lack of
acidic groups other than the two Kdo and lipid A phosphates
and the mannose-GlcN branch account for the role of Brucella
core in virulence both in cellular and animal models. By virtue
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FIGURE 1 | Schematic representation of Brucella melitensis LPS core. The
site of action of the glycosyltransferases identified thus far is indicated with
arrows. Kdo (3-deoxy-D-manno-octulosonic acid), Glc (glucose), Man
(mannose), GlcN (glucosamine), and Quin (quinovosamine) [adapted from
Fontana et al. (2016) and Gil-Ramírez et al. (2014)].
of the density of amino groups and close position to the inner
core and lipid A, the GlcN tetrasaccharide both neutralizes
and sterically protects those inner anionic groups, thereby
hampering binding of bactericidal peptides and PRRs such as
the activators of the antibody-independent classical complement
pathway and MD2, the TLR4 co-receptor. Accordingly, core
defects bolster proinflammatory responses causing an activation
of innate immunity earlier than that of the wild type, thereby
generating attenuation (Conde-Álvarez et al., 2012; Gil-Ramírez
et al., 2014; Soler-Lloréns et al., 2014; Fontana et al., 2016).
Also, although both wadB and wadC mutants maintain an intact
O-PS, attenuation in mice is more severe for the latter (Conde-
Álvarez et al., 2012; Gil-Ramírez et al., 2014; Fontana et al.,
2016) strongly suggesting a correlation between the extent of
core damage and the intensity of the immunoactivation that
brings about attenuation. A complete elucidation of the genetics
of Brucella LPS core could confirm such a correlation and,
since LPS core mutants represent a tool for developing a new
generation of brucellosis vaccines (Conde-Álvarez et al., 2013;
Zhao et al., 2017), also provide a graded array of possibilities.
With these possibilities in mind, we investigated B. abortus
2308 genes annotated as glycosyltransferases for their possible
involvement in LPS core synthesis and relevant biological
effects.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains and plasmids used in this study are
listed in Supplementary Table S1. All bacteria were grown
either on tryptic soy agar (TSA, Pronadisa) plates or in tryptic
soy broth (TSB, Scharlau) or Mueller-Hinton broth (Becton
Dickinson, Difco) at 37◦C. Where indicated, growth media were
supplemented with kanamycin (Km) at 50 mg/ml, nalidixic acid
(Nal) at 25 mg/ml, ampicillin (Amp) at 100 mg/ml, and/or
5% sucrose. Bacterial growth rates were determined at 37◦C
in Mueller–Hinton broth (Becton Dickinson, Difco), using a
Bioscreen C apparatus (Lab Systems). All strains were stored
in skim milk at −80◦C. Work with Brucella was performed
at the Biosafety Level 3 (BSL-3) laboratory facilities of the
“Centro de Investigación Médica Aplicada de la Universidad de
Navarra” (CIMA) and “Centro de Investigación y Tecnología
Agroalimentaria de Aragón” (CITA), Spain.
DNA Manipulations and Analyses
Sequence data were obtained from Kyoto Encyclopedia of
Genes and Genomes (KEGG2). Searches for DNA and protein
homologies between Brucella species and other α-proteobacteria
such asOchrobactrum,Rhizobium, orAgrobacteriumwere carried
out using KEGG, Basic Local Alignment Sequence Tool (BLAST3),
and Clustal Omega4 from the European Molecular Biology
Laboratory – European Bioinformatics Institute (EMBL-EBI5).
New glycosyltransferase identification, using B. abortus 2308 was
supported by Carbohydrate-Active enZymes database (CAZy6).
Primers were designed using Primer 3 input7 and synthesized
by Sigma–Aldrich. Plasmid DNA was extracted with Qiaprep
spin Miniprep (Qiagen GmbH). When needed, DNA was purified
from agarose gels using Qiack Gel extraction kit (Qiagen) and
sequenced by the Servicio de Secuenciación of CIMA.
Construction of Mutants
Open-reading frames (ORFs) BAB2_0133, BAB2_0135,
BAB2_0105, and BAB1_1620 were mutagenized by in frame
non-polar deletion in B. abortus 2308W (Supplementary
Table S1).
For the construction of Ba1BAB2_0133 mutant, we first
generated two PCR fragments: oligonucleotides BAB2_0133-F1
(5′-GCGTTGGACAAGTTGAGGTT-3′) and BAB2_0133-R2
(5′-CATAGCGGTCGGTTAAATGC-3′) were used to
2http://www.genome.jp/kegg/
3http://blast.ncbi.nlm.nih.gov/Blast.cgi
4http://www.ebi.ac.uk/Tools/msa/clustalo
5http://www.ebi.ac.uk/
6http://www.cazy.org
7http://bioinfo.ut.ee/primer3-0.4.0/
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amplify a 572 base pairs (bp) fragment including codons
1–38 of BAB2_0133, as well as 458 bp upstream of the
BAB2_0133 start codon. Oligonucleotides BAB2_0133-F3 (5′-
GTATCGCCAGCCAATTTACGTCCGTATTGGAAGCCAAGA
A-3′) and BAB2_0133-R4 (5′-CAGTAACAAAAGGCCG
CTAT-3′) were used to amplify a 442 bp fragment including
codons 299–326 of BAB2_0133 and 355 bp downstream of
the BAB2_0133 stop codon. Both fragments were ligated
by overlapping PCR using oligonucleotides F1 and R4 for
amplification, and the complementary regions between R2
and F3 for overlapping. The resulting fragment, containing
the BAB2_0133 deletion allele, was cloned into pCR2.1
(Invitrogen), to generate plasmid pMSB-01, sequenced to
ensure the maintenance of the reading frame, subsequently
subcloned into the BamHI and the XbaI sites of the suicide
plasmid pJQK (Scupham and Triplett, 1997) and transformed
into competent E. coli S17 λpir (Simon et al., 1983). The
resulting suicide pJQK-derived plasmid was introduced into
B. abortus 2308 by conjugation. The first recombination
event (integration of the suicide vector in the chromosome) was
selected by Nal and Km resistance, and the second recombination
(excision of the mutator plasmid leading to construction of the
mutant by allelic exchange) was selected by Nal and sucrose
resistance and Km sensitivity. The resulting colonies were
screened by PCR with primers F1 and R4 which amplified a
fragment of 1014 bp in the mutant and 1794 bp in the sibling
strain that keeps the wild-type gene. Primers BAB2_0133-F1
and BAB2_0133-R5 (5′-AAGACCCAGTAGTTAGCACT-3′)
amplified a fragment of 919 bp only in the wild-type strain.
The mutation generated results in the loss of the 80% of the
ORF.
Ba1BAB2_0135 mutant was constructed following the
same procedure and using oligonucleotides BAB2_0135-F1
(5′-TGGCGGCCGCTCTAGAACACCGGACTGCCTGATAA-3′)
and BAB2_0135-R2 (5′-CGGGCAATTTCGGCATAG-3′)
that amplified a 240 bp fragment including codons 1–40 of
BAB2_0135, as well as 120 bp upstream of the BAB2_0135
start codon, and oligonucleotides BAB2_0135-F3 (5′-CT
ATGCCGAAATTGCCCGCCGGTTTGGAAATGCGGTCAA-3′)
and BAB2_0135-R4 (5′-ATCCACTAGTTCTAGTT
ATGTAGCCGCCACCGTTT-3′) that amplified a 232 bp
fragment including codons 441–478 of BAB2_0135 and 115 bp
downstream of the BAB2_0135 stop codon. The resulting
colonies were screened by PCR with primers F1 and R4 that
amplified a fragment of 472 bp in the mutant and 1672 bp in the
sibling strain that keeps the wild-type gene. Primers BAB2_0135-
F1 and BAB2_0135-R5 (5′-CGATTGCCAGTCCCAGAAAG-3′)
amplified a fragment of 628 bp only in the wild-type strain. The
mutation generated results in the loss of the 84% of the ORF.
For the construction of Ba1BAB2_0105 mutant,
oligonucleotides BAB2_0105-F1 (5′-GCGTGTTCTACAGCCA
TGAA-3′) and BAB2_0105-R2 (5′-CCGCCGAAATGTAGG
AAGTG-3′) amplified a 198 bp fragment including codons
1–33 of BAB2_0105, as well as 99 bp upstream of the
BAB2_0105 start codon. Oligonucleotides BAB2_0105-F3 (5′-
CACTTCCTACATTTCGGCGGTATGTTGGATTGGGACGGG
T-3′) and BAB2_0105-R4 (5′-GCCGAATATGACGCTTGCTA-
3′) amplified a 154 bp fragment including codons 307–330 of
BAB2_0105 and 79 bp downstream of the BAB2_0105 stop
codon. The resulting colonies were screened by PCR with
primers F1 and R4 which amplified a fragment of 352 bp in
the mutant and 1171 bp in the sibling strain which keeps the
wild-type gene. Primers BAB2_0105-F1 and BAB2_0105-R5
(5′-CAAAGACCGGATATTGCGGG-3′) amplified a fragment of
550 bp only in the wild-type strain. The mutation results in the
loss of the 83% of the ORF.
Ba1BAB1_1620 mutant was constructed using
oligonucleotides 1620-F1 (5′-GTACGCGGTCGTAGCTCAGT-
3′) and 1620-R2 (5′-CTCAAACTGAGACGCCATGA-3′),
that amplified a 475 bp fragment including codons
1–23 of BAB1_1620 as well as 406 bp upstream of
the ORF start codon. Oligonucleotides 1620-F3 (5′-
TCATGGCGTCTCAGTTTGAGATAGCCAACGTCACCAAAA
CA-3′) and 1620-R4 (5′-CTCTGCAATTCTTGCGATCA-3′)
were used to amplify a 410 bp fragment including codons
241–261 of the BAB1_1620 ORF and 347 bp downstream of the
BAB1_1620 stop codon. Both fragments were ligated, cloned into
pCR2.1 to generate plasmid pYRI-16, and subcloned into the
suicide pJQK (pYRI-17). After conjugation with B. abortus, the
resulting colonies were screened by PCR with primers 1620-F1
and 1620-R4 which amplified a 885 bp fragment in the mutant
and 1536 bp in the parental strain. The mutation generated
results in the loss of the 83% of the BAB1_1620 ORF.
The rest of the ORFs were mutagenized by recombination
and gene disruption using as suicide vectors pJQK or pSKoriT
(Tibor et al., 2002) carrying an internal fragment of the
ORF.
For the construction of Ba::pJQK-BAB1_0114 mutants, we
generated a PCR fragment using oligonucleotides BAB1_0114-
F1 (5′-TCAACAAATCGGCCAAGGAC-3′) and BAB1_0114-R2
(5′-GTCACGCGGTCAAACTGG-3′) which amplified a 481 bp
fragment containing the region that codes for amino acids
248–407. The fragment was cloned into pCR2.1, to generate
plasmid pMSB-17, sequenced and subcloned into the BamHI
and the XbaI sites of the suicide plasmid pJQK to obtain
pMSB-28, and then transformed into competent E. coli S17
and transferred into B. abortus 2308 by conjugation. The
integration of the suicide vector and disruption of the target
gene were selected by Nal and Km resistance and by PCR
combining BAB1_0114-F3 (5′-CCTATATTCCCCAGGCCGTT-
3′) with M13 Forward (5′-CTGGCCGTCGTTTTAC-3′) or with
M13 Reverse (5′-CAGGAAACAGCTATGAC-3′). These last
two primers hybridize in the suicide vector inserted in the
chromosome. BAB1_0114-F3 and M13 Forward amplified a
fragment of 881 bp only in the mutant strain. Following the same
strategy, we constructed the rest of insertion mutants:
Mutant Ba::pSKoriT-BAB1_0417 was obtained using
oligonucleotides BAB1_0417-F1 (5′-TGATCGACCATGGCTC
GG-3′) and BAB1_0417-R2 (5′-TCAAGCCTGACCAGAAGCC-
3′) which amplified a 295 bp fragment of BAB1_0417
(codon 37–134). The fragment was first cloned in pCR2.1
(pMSB-05), subcloned into the suicide plasmid pSKoriT
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(pMSB-06), and transferred into B. abortus 2308 by
conjugation. Primers M13 Reverse and BAB1_0417-F3 (5′-
CTGTTTCCCGACCAGCTTG-3′) amplified a fragment of
649 bp only in the mutant.
Oligonucleotides BAB2_0693-F1 (5′-CACTGCAAGCCG
GTTACAAT-3′) and BAB2_0693-R2 (5′-TGCAACGAAAT
TCTGTCCGG-3′) were used for the construction of
Ba::pJQK-BAB2_0693 mutant. F1 and R2 amplified a
fragment of 416 bp (codons 249–386). We generated
plasmid pMSB-16, subsequently subcloned into the suicide
plasmid pJQK (pMSB-24), and conjugated into B. abortus
2308. Primers M13 Forward and BAB2_0693-F3 (5′-
ACGAGCGCTATGATTTCGTC-3′) amplified a fragment
of 684 bp only in the mutant.
For the construction of Ba::pJQK-BAB1_0932 mutants
we used oligonucleotides BAB1_0932-F1 (5′-GCCGTCGTCCT
GAATGTTAC-3′) and BAB1_0932-R2 (5′-GCCATTATCCAG
TGCAGCC-3′) which amplified a 420 bp fragment of
BAB1_0932 (codons 354–493). We generated plasmid
pMSB-28, subsequently subcloned into the suicide plasmid
pJQK (pMSB-29), and conjugated into B. abortus 2308.
The resulting Nal–Km-resistant colonies were screened by
PCR. Primers M13 Reverse and BAB1_0932-F3 (5′-GGCC
GAGAATGGCTATATCA-3′) amplified a fragment of 915 bp
only in the mutant.
Mutant Ba::pSKoriT-BAB1_0326 was obtained using
oligonucleotides BAB1_0326-F1 (5′-GCACTCAACCGGCT
CAATTG-3′) and BAB1_0326-R2 (5′-AGCACCGCATATTCA
AAGGC-3′) which amplified a 368 bp fragment of BAB1_0326
(codons 261–383) that was cloned into pCR2.1 to obtain
pMSB-07. The fragment was then subcloned into the suicide
pSKoriT (pMSB-10), and conjugated into B. abortus 2308.
The resulting Nal–Km-resistant colonies were screened
by PCR. Primers M13 Reverse and BAB1_0326-F3 (5′-
ATGTTGCCATGTCGCTGTTT-3′) amplified a fragment of
678 bp only in the mutant strain.
Construction of Ba::pJQK-BAB1_0607 mutants was
carried out using oligonucleotides BAB1_0607-F1 (5′-
GCCAATGTCGTTCTCTCCAA-3′) and BAB1_0607-R2
(5′-CTTGGTGTCAGCCCCTTTTC-3′) which amplified
a 449 bp fragment of BAB1_0607 (codons 278–427). We
generated the pCR2.1-derived plasmid pMSB-19, then
subcloned into the suicide plasmid pJQK (pMSB-21), and
conjugated into B. abortus 2308. Primers M13 Forward
and BAB1_0607-F3 (5′-TTCTTTCCAATGAGCGCACC-
3′) amplified a fragment of 800 bp only in the
mutant.
We constructed two different mutants in ORF
BAB1_0953 (wadD). The first, Ba::pSKoriT-BAB1_0953,
carried the suicide vector inserted in the gene and
was obtained with oligonucleotides BAB1_0953-
F1 (5′-ACTTTTCGCCGAGCAACAAA-3′) and
BAB1_0953-R2 (5′-AGGCACGGTTTCATAGACGA-
3′) which amplified a 358 bp fragment of BAB1_0953
(codons 112–230). We generated plasmid pMSB-
11, subsequently subcloned into the suicide plasmid
pSKoriT (pMSB-12), and conjugated into B. abortus
2308. Primers M13 Forward and BAB1_0953-F3 (5′-
GCTGGCTTCATGAAATCCGT-3′) amplified a fragment
of 612 bp in mutant.
We also constructed a non-polar wadD mutant
(Ba1wadD) by in frame deletion. Oligonucleotides wadD-F1
(5′-TCTATAATGAGAGGCGGCTTTT-3′) and wadD-R2 (5′-A
GAAGTGCTGGTCCTGTTGT-3′) were used to amplify a 304
(bp) fragment including codons 1–50 of BAB1_0953, as well as
154 bp upstream of the BAB1_0953 start codon.
Oligonucleotides wadD-F3 (5′-ACAACAGGACCAGCACTT
CTATCCTCACCCTGCCATTCAA-3′) and wadD-R4 (5′-
CTGGTACTAGACGCCCTGTT-3′) were used to amplify a
175 bp fragment including codons 281–324 of BAB1_0953 and
43 bp downstream of the BAB1_0953 stop codon. Both fragments
were ligated by overlapping PCR using oligonucleotides F1 and
R4 for amplification, and the complementary regions between
R2 and F3 for overlapping. The resulting fragment, containing
the BAB1_0953 deletion allele, was cloned directly into pJQK by
the InFusion cloning system (Clontech) to generate pMSB-34.
This suicide vector was sequenced to ensure the maintenance
of the reading frame and transferred into B. abortus 2308 by
conjugation. The resulting colonies were screened by PCR
with primers F1 and R4 that amplified a fragment of 479 bp
in the mutant and 1169 bp in the sibling strain which keeps
the wild-type gene. Primers wadD-F1 and wadD-R5 (5′-
AGGCACGGTTTCATAGACGA-3′) amplified a fragment of
844 bp only in the wild-type strain. The mutation generated
results in the loss of the 71% of the ORF and the mutant was
called Ba1wadD.
Complementation of wadD Mutants
For complementation experiments, we performed a stable
insertion of the miniTn7 transposon into the chromosome of
Ba1wadD (Choi and Schweizer, 2006). For this purpose, we first
generated a PCR product using oligonucleotides Tn7-wadD-F1
(5′-CGGGCTGCAGGAATTGCGATTCCTTTGTGCCAGAT-3′)
and Tn7-wadD-R2 (5′-GCTTCTCGAGGAATTATCATCG
CCGCATTGAAGAC-3′), which amplified a 1771 bp fragment
including codons 1–323 of BAB1_0953 together with 481 bp
upstream of the ORF start codon including the putative wadD
promoter and 318 bp downstream the ORF stop codon. This
PCR product was cloned into the corresponding sites of
the linearized pUC18 R6KT miniTn7T KmR vector (Llobet
et al., 2009) to generate plasmid pMSB-44. The plasmid was
sequenced to ensure the maintenance of the reading frame
transformed into E. coli S17 and transferred to Ba1wadD
mutant by tetra-parental conjugation between E. coli S17
(pMSB44), E. coli SM10 λpir (pTNS2), and E. coli HB101
(pRK2013). The conjugants harboring pMSB-44 were selected by
plating the mating mixture onto TSA–Nal–Km plates that were
incubated at 37◦C for 4 days. To confirm that the transposon
was inserted between genes glmS and recG (Choi and Schweizer,
2006), we performed PCR using different oligonucleotides:
Tn7F (5′-TGGCTAAAGCAAACTCTTCATTT-3′) and Tn7R
(5′-GCGGATTTGTCCTACTCAGG-3′) allowed to confirm
that the Tn7 was inserted, oligonucleotides Glms_B (5′-GT
CCTTATGGGAACGGACGT-3′) and PTn7-R (5′-CACAGC
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ATAACTGGACTGATT-3′) confirmed that the transposon
was inserted immediately after the gene glmS, and RecG-R
(5′-TATATTCTGGCGAGCGATCC-3′) and PTn7-L (5′-ATTAG
CTTACGACGCTACACCC-3′) confirmed that the transposon
was inserted before the gene recG (Choi and Schweizer, 2006).
The resulting strain was named Ba1wadD::Tn7-PwadD.
Crystal Violet Exclusion Test
To study if the mutants had smooth (complete LPS) or rough (O-
PS-lacking LPS) phenotype, 5 ml of a crystal violet solution at
0.1 mg/ml in distilled water were used to cover isolated colonies
on TSA plates for 20 s. Smooth colonies excluded crystal violet
and looked white, whereas rough colonies captured crystal violet
and looked violet.
LPS Extraction and Characterization
LPS was extracted by the proteinase-K sodium dodecyl sulfate
(SDS) protocol (Dubray and Limet, 1987; Garin-Bastuji et al.,
1990) with some modifications. Bacteria grown overnight in
10 ml of TSB were killed with 0.5% phenol during 3 days in
agitation at 37◦C. After that, samples were weighed and pipetted
into small polycarbonate cap tubes and then suspended by
ultrasounds in 2% SDS–60 mM Tris–HCl buffer (pH 6.8) at a
concentration of 0.5 g (wet weight) of bacteria per 10 ml of buffer.
Samples were then heated at 100◦C for 10 min, and lysates were
cooled to 55◦C. This treatment was followed by digestion with
60 µl of proteinase-K at 2.5 mg/ml in HCl–Tris per ml of sample
(Merck KGaA) for 3 h at 55◦C, and overnight incubation at
20◦C. Afterward, they were centrifuged at 20,000 × g for 30 min
at room temperature, and the LPS was precipitated from the
supernatant by addition of 3 volumes of methanol containing
1% sodium acetate-saturated methanol at −20◦C. After 60 min,
the precipitate was harvested by centrifugation at 5,000 × g for
15 min at 4◦C and resuspended by sonication in 10 ml of distilled
water. After a second methanol precipitation and centrifugation,
the pellets were resuspended by sonication in 2–3 ml of 60 mM
HCl–Tris (pH 6.8) and left at 37◦C. Then samples were treated
with 20 µl/ml of RNase and DNase stock solutions at 0.5 mg/ml
in HCl–Tris (MP Biomedicals and Sigma–Aldrich, respectively)
at 37◦C for 30 min. Subsequently, the LPS was treated again with
5 µl/ml of proteinase K at 2.5 mg/ml in HCl–Tris, at 55◦C for 3 h
and then, at room temperature overnight. After a third methanol
precipitation in the same conditions described above, the pellet
containing LPS was recovered in 1 ml of distilled water and frozen
at−20◦C.
SDS–PAGE and Western Blots
Samples were mixed 1:1 with Sample buffer 2× (Bio-Rad), heated
at 100◦C for 10 min, and analyzed in Tris–HCl–glycine-12,
15, or 18% polyacrylamide gels (37.5:1 acrylamide/methylene–
bisacrylamide ratio). Fifteen microliters of each sample were run
at 30 mA constant current for 140 min. Finally, LPS molecules
were revealed by the periodate-alkaline silver method (Tsai and
Frasch, 1982).
For Western blot, gels were electro-transferred onto PVDF
sheets (Whatman, Schleicher & Schuell, WESTRAN S.; 0.2 µm
pore size) in a transfer buffer (pH 8.3) containing 0.025 M
Tris, 0.192 M glycine, and 20% (vol/vol) methanol. Transfer was
performed at a constant voltage of 8 V and 200 mA for 30 min
in a Trans-Blot Semi-Dry Transfer Cell (Bio-Rad). Antibodies
used were MoAbs A68/24D08/G09 and A68/24G12/A08, which
recognize core epitopes (Bowden et al., 1995), and a polyclonal
serum from a rabbit infected with B. melitensis 16 M and bled at
day 45.
Enzyme-Linked Immunosorbent Assay
(ELISA)
Enzyme-Linked Immunosorbent Assay using whole bacteria
(sonicated cells) as the antigen were performed as described
previously (Cloeckaert et al., 1993a). MoAbs used were directed
against O-PS, R-LPS, and the OM lipoproteins Omp10, Omp16,
and Omp19 (Cloeckaert et al., 1990, 1993a,b, 1998). The anti-R-
LPS MoAbs used were A68/03F03/D05 (IgG2b), A68/10A06/B11
(IgM), A68/24D08/G09 (IgG1), and A68/24G12/A08 (IgG3). The
MoAbs specific for the O-PS epitopes were 2E11 (IgG3; M
epitope), 12G12 [IgG1; C (A = M) epitope], 07F09 [IgG1; C
(A = M) epitope], 12B12 [IgG3; C (M > A) epitope], 18H08
[IgA; C/Y (A = M) epitope], 04F9 [IgG2a; C/Y (A>M) epitope],
and 05D4 [IgG1; C/Y (A > M) epitope]. The MoAbs specific
for OM lipoproteins were A68/08E07/B11 (Omp10; IgG2a),
A68/04G01/C06 (Omp16; IgG2a), A76/08C03/G03 (Omp16;
IgG2a), and A76/10D03/H02 (Omp19; IgG2b). All MoAbs were
used as hybridoma supernatants in ELISA.
Sensitivity to Polycationic Bactericidal
Peptides
The minimal inhibitory concentration (MIC) of polymyxin B and
poly-L-ornithine (both from Sigma–Aldrich) were determined
in Mueller–Hinton medium. Exponentially growing bacteria
were adjusted to an OD equivalent to 1 of the McFarland
scale, and exposed to serial dilutions of the bactericidal
peptides. MICs were determined by technical duplicates after
2 days of incubation at 37◦C. Experiments were performed in
triplicate.
Sensitivity to the Bactericidal Action of
Non-immune Serum
Exponentially growing bacteria were adjusted to 104 Colony
Forming Units (CFU)/ml in saline and dispensed in duplicate
in microtiter plates (30 µl/well) containing 60 µl of new-
born bovine serum. After 90 min of incubation at 37◦C with
gentle agitation, complement action was blocked by adding
brain heart infusion (BHI) broth (150 µl/well). After mixing
the BHI broth with the bacterial suspension, 75 µl were plated
by triplicate on TSA plates. Five days after incubation at 37◦C,
results were expressed as the percentage of CFU recovered with
respect to control samples where new-born bovine serum was
substituted by PBS. The experiment was repeated three different
times.
Virulence in Mice
Seven-week-old female BALB/c mice (ENVIGO, Harlan) were
lodged in cages in BSL-3 facilities with water and food
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ad libitum for 2, 8, or 12 weeks. Six groups of five mice
each were inoculated with Ba1wadD or Ba-parental. Inocula
were prepared in sterile PBS and each mouse was administered
intraperitoneally approximately with 5 × 104 CFU in 0.1 ml.
To assess the exact dose retrospectively, dilutions of each
inoculum were plated by triplicate on TSA plates. Spleen CFUs
in infected mice were counted at 2, 8, and 12 weeks after
inoculation. The CFU counts were normalized by logarithmic
transformation and the mean log CFU/spleen values and
the standard deviations were calculated. The spleens were
weighed and homogenized in 9 volumes of PBS and serial
10-fold dilutions were accomplished and plated by triplicate
on TSA plates. After 5 days of incubation at 37◦C the
colonies were checked by crystal violet exclusion test and
PCR.
Statistical Analysis
Statistical significance for sensitivity to normal serum was
evaluated with one-way ANOVA followed by Dunnett’s multiple
comparisons test (∗∗∗∗p < 0.0001). For virulence analysis,
statistical significance between the parental strain and the wadD
mutant was evaluated using Student’s t-independent-samples test
(∗p< 0.05).
RESULTS
Screening for Putative LPS Core
Glycosyltransferases
A bioinformatic search in the Carbohydrate-Active Enzymes
database CAZy8 revealed 23 ORFs in the genome of
B. abortus 2308 (Supplementary Table S1) that could code
for glycosyltransferases. We excluded from further analysis
BAB1_0108-cgs, which is involved in cyclic glucan synthesis
(Briones et al., 2001), BAB1_1786-mtgA and BAB1_1450-murG,
both related to peptidoglycan synthesis, BAB1_1171-lpxB,
probably implicated in lipid A formation (Iriarte et al., 2004),
and BAB1_0553-wbkA, BAB1_0563-wbkE; BAB1_1000-wboA
and BAB1_1000-wboB, four genes that belong to the O-PS
synthesis route (McQuiston et al., 1999; Godfroid et al., 2000;
González et al., 2008). Similarly, four ORFs correspond to
those glycosyltransferases already known to be involved in the
synthesis of the LPS core: BAB1_0639-wadA (Monreal et al.,
2003), BAB1_0351-wadB (Gil-Ramírez et al., 2014), BAB1_1522-
wadC (Conde-Álvarez et al., 2012), and BAB2_0209-waaA
(Iriarte et al., 2004) (see the section “Introduction”). The
remaining 11 ORFs are listed in Table 1, and data on their
presence in other Brucella spp. and genetic location are in
the Supplementary Material (Supplementary Table S2 and
Supplementary Figure S1). Of these, seven (BAB1_0953,
BAB2_0105, BAB2_0133, BAB2_0135, BAB1_1620, BAB1_0607,
and BAB1_0932) were highly conserved in all Brucella spp., but
four (BAB2_0693, BAB1_0417, BAB1_0114, and BAB1_0326)
presented significant differences when compared to B. abortus
sequences, mainly due to frameshifts generating shorter proteins
8http://www.cazy.org
(Supplementary Table S2). Perusal of the literature revealed
some information on 4 of those 11 putative glycosyltransferases.
Expression of BAB1_0326, BAB2_0133, and BAB2_0135 has
been shown to be controlled by MucR, a general virulence
regulator in Brucella (Caswell et al., 2013). However, although
it has been reported that B. abortus and B. melitensis mucR
mutants have a defective LPS core, the glycosyltransferases
involved have not been identified (Caswell et al., 2013; Mirabella
et al., 2013). Also, BAB1_1620 expression has been reported
to be controlled by BvrR/BvrS, a master regulator of Brucella
virulence that modulates OM homeostasis and undetermined
aspects of LPS structure (Manterola et al., 2005; Viadas et al.,
2010).
We first analyzed the MucR and BvrR/BvrS controlled ORFs
for involvement in LPS synthesis. To this end, we constructed
an insertion mutant in BAB1_0326 (since the downstream
ORF is oriented in the opposite direction) as well as non-
polar deletion mutants in BAB2_0133 and BAB2_0135 (both
part of an operon), and BAB1_1620 (which, although isolated,
is surrounded by genes implicated in the cell cycle). These
four mutants maintained the S phenotype in the crystal violet
assay, suggesting that they kept an intact O-PS. Then, SDS–
proteinase-K LPSs were analyzed by SDS–PAGE and Western
blot with both a polyclonal serum against S brucellae and anti-
core MoAbs A68/24G12/A08 and A68/24D08/G09, using as
controls LPS from B. abortus 2308W (Ba-parental), a B. abortus
wadC mutant (Ba1wadC), and a R per mutant (Ba1per)
(Martínez-Gómez et al., 2018). The LPS of the four mutants
presented S and R fractions with migration profiles identical to
those of Ba-parental LPS and reacted similarly with the serum
and MoAbs (Supplementary Figure S2) strongly suggesting
that the corresponding ORFs are not required for normal
LPS synthesis. When we complemented these observations
by inoculating BALB/c mice with BAB2_0133, BAB2_0135,
and BAB1_1620 mutants, they produced CFU/spleen that did
not differ from those of Ba-parental at weeks 2 (p = 0.99;
0.75 and 0.45, respectively) and 8 (p = 0.95; 0.99 and
0.99) after infection. Moreover, mutants in BAB2_0133 and
BAB1_1620 behaved similarly to Ba-parental in polycationic
peptide resistance, and the former also performed as Ba-parental
in sensitivity to normal serum (Supplementary Figure S3).
These results are consistent with the idea that the putative
glycosyltransferases regulated by MucR or BvrR/BvrS are not
involved in the synthesis of LPS or of other components
implicated in virulence, at least under the conditions used in this
study.
To investigate whether the remaining seven putative
glycosyltransferases (BAB1_0953, BAB2_0105, BAB2_0693,
BAB1_0607, BAB1_0114, BAB1_0932, and BAB1_0417) were
required for LPS synthesis, we constructed B. abortus 2308W
insertion mutants in each of them. All mutants were S by
the crystal violet assay and the analysis of the extracted
LPS showed S fractions with a migration profile like that of
Ba-parental and reacted similarly with the anti S-Brucella
polyclonal serum (Figure 2 and Supplementary Figure S4).
Interestingly, although keeping the S fraction, mutant in
BAB1_0953 lost reactivity in the R fraction, suggesting a
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TABLE 1 | ORF coding for B. abortus hypothetical glycosyltransferases, family to which they belong, predicted function, and the corresponding mutant LPS phenotype
by Western blot analysis.
ORF Family Predicted function (KEGG) Mutant LPS reactivity
O-PSa R-LPSb
BAB1_0326 2 Glycosyltransferase + +
BAB2_0133 2 Glycosyltransferase + +
BAB2_0105 2 Glycosyltransferase + +
BAB2_0693 2 Glycosyltransferase + +
BAB1_0953 2 Glycosyltransferase + −
BAB1_1620 25 Glycosyltransferase + +
BAB1_0607 51 Penicillin-binding protein 1A transpeptidase domain – Glycosyltransferase + +
BAB1_0114 51 Penicillin-binding protein transpeptidase domain: ATP/GTP-binding site motif A (P-loop) – Glycosyltransferase + +
BAB1_0932 51 Penicillin-binding protein 1A transpeptidase domain – Glycosyltransferase + +
BAB2_0135 83 Possible dolichyl-phosphate-mannose-protein mannosyltransferase family protein + +
BAB1_0417 ncc Conserved hypothetical protein + +
aReactivity to polyclonal serum from a rabbit infected with B. melitensis 16M. bReactivity to monoclonal antibodies anti-R-LPS: A68/24G12/A08 and A68/24D08/G09.
cGlycosyltransferase family non-classified.
FIGURE 2 | Mutation of B. abortus BAB1_0953 but not of other candidate for
LPS glycosyltransferase genes abrogates reactivity of the R-LPS but not of
the S-LPS fraction with antibodies from a B. melitensis-infected rabbit.
Ba1per is a N-formyl-perosamine synthase mutant lacking the LPS O-PS,
and Ba1wadC is a LPS mutant bearing O-PS but defective in the
mannose-tetraglucosamine lateral branch of the core oligosaccharide
(Figure 1).
defect in the core and/or lipid A epitope(s) recognized by
polyclonal sera of infected animals (Rojas et al., 2001). Since
this was not observed for the other mutants, we investigated
further BAB1_0953 and the phenotype associated with its
mutation.
BAB1_0953 Encodes WadD, a Previously
Unidentified Glycosyltransferase
Involved in the Synthesis of the LPS Core
Lateral Branch
BAB1_0953 is an isolated gene and the adjacent ORFs are
encoded in the complementary strand. Thus, it was very
unlikely that a polar effect caused the LPS phenotype of the
insertion mutant. However, to rule out such a possibility,
we constructed a non-polar deletion mutant, hereafter named
Ba1wadD following the nomenclature previously established
for Brucella LPS core genes (Reeves et al., 1996; Gil-Ramírez
et al., 2014). Ba1wadD LPS showed a migration profile
similar to that of Ba-parental in the high molecular weight
S-LPS fraction and an increased mobility in the R-LPS one.
Western-blot analysis with a polyclonal serum showed that,
while the former fraction kept the reactivity with this serum,
the latter failed to react indicating a significant alteration of
the core-lipid A epitopes. To assign the defect to the core
oligosaccharide, we probed the LPS with MoAbs A68/24G12/A08
and A68/24D08/G09, the binding of which to the R-LPS
requires an intact mannose-GlcN tetrasaccharide (Conde-
Álvarez et al., 2012; Fontana et al., 2016). Both antibodies
failed to react with the R-LPS fraction and this failure was
reverted upon insertion of a complete wadD gene in the
bacterial chromosome of the deletion mutant (Ba1wadD::Tn7-
PwadD). Moreover, this complementation restored both the
migration pattern of the R-LPS fraction to the level of the
Ba-parental LPS and the reactivity with the polyclonal serum
(Figure 3). An ELISA with several anti-core MoAbs and
whole bacteria confirmed the core defect (Figure 4, upper
panel).
We only observed small but constant differences in reactivity
of Ba-parental and Ba1wadD with anti-Outer Membrane
Proteins (OMP) antibodies (Figure 4, lower panel). Although
considering the limitations of the method used, this suggests
that the presence of the O-PS and the defect in the core
LPS could generate a steric hindrance that would allow the
access of antibodies to the OMPs (Bowden et al., 1995) or
the possibility that wadD mutation could affect the amount
of LPS in the OM or how it is inserted in the bacterial
surface.
Although as signaled above, the final confirmation
would require a complete chemical analysis, all these results
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FIGURE 3 | Mutation of wadD generates an LPS core defect. Left panel, SDS–PAGE electrophoresis and silver staining of SDS–proteinase K extracts; central panel,
Western blot analysis of SDS–proteinase K extracts with a polyclonal serum of a B. melitensis-infected rabbit; right panel, Western blot analysis of SDS–proteinase K
extracts with monoclonal anti-core antibody A68/24G12/A08.
strongly suggest that wadD encodes a previously unidentified
glycosyltransferase involved in the synthesis of the core lateral
branch.
WadD Orthologs Are Present in all
Brucella spp. but in a Recently
Characterized Isolate From Amphibians
In silico analysis (Supplementary Figure S5) showed that
wadD was highly conserved in the core brucellae including
the “classical” spp. B. melitensis, B. suis (smooth LPS), and
B. ovis and B. canis (rough LPS) and also in other “non-
classical” smooth Brucella spp.: B. pinnipedialis, B. microti,
B. ceti, and B. vulpis. We also analyzed the presence of
wadD in the group of early-diverging brucellae that depart
from the classical spp. and includes B. inopinata strain
BO1, B. inopinata-like strain BO2, an isolated strain from
native rodents in Australia (NF2653), and the Brucella spp.
recently isolated from amphibians. These early-diverging
Brucella produce an atypical LPS (Scholz et al., 2010;
Tiller et al., 2010; Soler-Lloréns et al., 2016; Al Dahouk
et al., 2017). Unexpectedly, wadD was present in all of
them but absent in Brucella spp. B13-0095, one of the four
Brucella strains isolated from frogs that have been completely
sequenced (Soler-Lloréns et al., 2016). In contrast, this strain
conserves wadB and wadC. Finally, WadD was 72 and 71%
homologous to Ochrobactrum anthropi and O. intermedium
orthologs, respectively, two species that also belong to the α-2
Proteobacteria subclass and are the closest genetic neighbors of
Brucella.
Dysfunction of wadD Generates
Increased Sensitivity to Cationic
Peptides and Normal Serum
To test if the core defect displayed by Ba1wadD affected
resistance to polycationic peptides, we used poly-L-ornithine,
a mildly bactericidal cationic peptide and the two known
core mutants Ba1wadB and Ba1wadC plus the parental
strain as controls. The results (Figure 5A) showed that
wadD dysfunction brought about a sensitivity similar to
that of Ba1wadB but inferior to that of Ba1wadC. These
differences in sensitivity were not due to growth defects
because Ba1wadD had a growth rate similar to that of
Ba-parental, and experiments with the highly bactericidal
lipopeptide polymyxin B confirmed the role of wadD
(Ba1wadD MIC = 0.094 µg/ml versus MIC = 2 µg/ml for
both the mutant complemented with wild-type wadD and
Ba-parental).
S brucellae are resistant to the bactericidal action of
normal serum, a property associated with both the O-PS
hindrance to inner OM targets such as OMPs and the
PAMP modifications of the core that reduce binding of the
complement activators of the antibody-independent classical
pathway (Conde-Álvarez et al., 2012; Gil-Ramírez et al., 2014;
Fontana et al., 2016). We compared the sensitivity to newborn
bovine and ovine serum of Ba-parental and wadB, wadC,
or wadD mutants and observed that the three core mutants
were more sensitive than Ba-parental. The effect was more
remarkable for mutant wadC than for wadD or wadB mutants
(Figure 5B).
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FIGURE 4 | Outer membrane epitopes in Ba1wadD and Ba-parental. Upper panel, anti-O-PS and anti-R-LPS; lower panel, anti-OMP antibodies measured by
ELISA test.
Dysfunction of wadD Generates
Attenuation Detectable in the Chronic
Phase in the Mouse Model
To analyze the role of wadD in virulence, we infected BALB/c
mice (n = 5) with Ba1wadD or Ba-parental and compared the
CFU/spleen at weeks 2, 8, and 12 (Figure 6). At weeks 8 and 12
post-infection, the CFU numbers of Ba1wadD were significantly
lower than those of Ba-parental (p = 0.0003 and p = 0.0073,
respectively), showing that wadD is required for full Brucella
virulence in mice. This result is in line with previous observations
with wadB and wadC mutants (Conde-Álvarez et al., 2012; Gil-
Ramírez et al., 2014) and further confirms that an intact LPS core
is necessary for virulence.
DISCUSSION
In this work, we have analyzed the role of ORFs BAB1_0114,
BAB1_0417, BAB2_0693, BAB1_0932, BAB1_0607, BAB2_0105,
BAB1_1620, BAB2_0133, BAB2_0135, and BAB1_0326
annotated as glycosyltransferases in the B. abortus genome.
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FIGURE 5 | Dysfunction of wadD increases the sensitivity to poly-L-ornithine
and non-immune sera. (A) Poly-L-ornithine MIC determined by the serial
dilution method (results representative of three independent experiments in
which Ba-parental, Ba1wadC, Ba1wadB, and Ba1wadD were assayed
simultaneously). (B) Survival after incubation for 90 min in bovine non-immune
serum (media ± standard error of technical triplicates). Means were compared
by one-way ANOVA followed by Dunnett’s multiple comparisons test
(∗∗∗∗p < 0.0001). Differences were significative between wadC and wadB
mutants (p = 0.0023), between wadC and wadD mutants (p < 0.0001), but
not between wadB and wadD mutants (p = 0.1958).
Our results indicate that mutants in these ORFs react similarly
to the parental strain in the S and R-LPS fractions and suggest
that, in the studied conditions and with the available techniques,
they seem not to be required for the synthesis of a complete
LPS. Interestingly, the last three ORFs have been shown to be
controlled by mucR, a regulator of Brucella virulence. Although it
has been reported that B. abortus and B. melitensis mucR mutants
have a defect in the core LPS (Caswell et al., 2013; Mirabella et al.,
2013), the glycosyltransferases responsible for this defect have
not been identified. In this work we have shown that mutation
of the mucR-regulated putative glycosyltransferases BAB2_0133,
BAB2_0135, and BAB1_0326 (Caswell et al., 2013) does not
affect the synthesis of the core, at least in the growth conditions
tested. Nevertheless, since the expression of these genes seems to
be repressed by mucR (Caswell et al., 2013), a single mutation in
the ORF could not be sufficient for the complete clarification of
their role in LPS synthesis and further work would be required.
We have also analyzed in detail the role of the hypothetical
glycosyltransferase BAB1_1620, as it is regulated by the master
two-component regulator BvrR/BvrS that controls Brucella
FIGURE 6 | Mutants in wadD showed slight attenuation at late stage of
infection. Spleen CFUs in infected BALB/c mice were counted at 2, 8, and
12 weeks after inoculation of 5 × 104 CFU. Means were compared by
Student’s t independent-samples test (∗p < 0.05). For mice infected with the
parental strain the counts were 6.25 ± 0.38, 6.98 ± 0.24, and 5.85 ± 0.32,
respectively, and for mice infected with the wadD mutant 6.56 ± 0.22,
6.28 ± 0.54, and 5.17 ± 0.27.
virulence and the expression of surface components. According
to our results, this ORF is not required for the synthesis of
a complete LPS and is not implicated in surface-dependent
characteristics that confer resistance to polycationic peptides or
in virulence in the mouse model.
More interestingly, we report the identification of wadD,
a gene encoding a previously unidentified glycosyltransferase
involved in the synthesis of the core section not linked to the
O-PS and thus, corroborate and extend previous work indicating
that the Brucella LPS core is a branched structure that constitutes
a steric impairment preventing the elements of the innate
immune system to fight against Brucella (Conde-Álvarez et al.,
2012; Kubler-Kielb and Vinogradov, 2013; Gil-Ramírez et al.,
2014; Fontana et al., 2016), and contribute to Brucella virulence.
The discovery of genes wadC and wadB, involved in the
synthesis of the lateral branch not linked to the O-PS, was critical
for the understanding of the structure and the role of the core
section in virulence. It has been clearly demostrated that in a
wadC mutant, the complete core lateral branch is absent because
this mutant cannot incorporate the mannose residue that is the
depart of the lateral branch and it links to the lipid A-core section
(Conde-Álvarez et al., 2012; Fontana et al., 2016). In accordance,
deletion of wadC results in higher sensitivity to polycationic
peptides and complement, better recognition by the CD14–
MD2–TLR4 receptor complex, maturation of dendritic cells,
secretion of pro-inflammatory cytokines (including Th1-type
cytokines IL-12 and IFN-γ), and attenuation in mice (Conde-
Álvarez et al., 2012; Fontana et al., 2016). A wadB mutant is
also more sensitive to elements of the innate immune system
and shows attenuation in mice, although not to the levels of
the wadC mutant (Gil-Ramírez et al., 2014). As we show here,
disruption of wadD in B. abortus leads to a S strain with a core
defect less severe than that of the wadC mutant, more sensitive to
polycationic peptides and normal serum than the parental strain
and attenuated in the murine model. Interestingly, its sensitivity
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to polycationic peptides is similar to that of the wadB mutant
(Gil-Ramírez et al., 2014) and not as strong as that of the wadC
mutant (Conde-Álvarez et al., 2012), that has lost the complete
branch, and its role in virulence became apparent already at
8 weeks post-infection.
The resistance to polycationic peptides and the bactericidal
action of normal serum of mutant wadD strongly suggest a role
in thwarting some effectors of innate immunity and that this
could be manifested in the early stages of infection. However,
to observe these effects would depend on the virulence model
used. Indeed, the results obtained in an in vitro test, where
the bacteria are put directly in contact with the polycationic
peptides or with the serum can not be completely extrapolated
to all situations in the in vivo model where other factors apart
from polycationic peptides and complement are clearly taking
part during the infection process. Still, the mouse model is the
only well-characterized laboratory model for Brucella virulence
studies and requires that mice are inoculated by the IP route. By
this route, bacteria are not in contact with polycationic peptides
or serum proteins at the beginning of the infection process as they
are taken up and transported to the spleen rapidly. Nevertheless,
the attenuation observed for Brucella LPS core mutants is caused
by an early activation of innate immunity, as we have proved
before (Conde-Álvarez et al., 2012; Fontana et al., 2016).
Our results would be compatible with the loss of one or few
glucosamine residues in the lateral branch of the wadD mutant,
and with the fact that removal of these residues would cause an
increase in overall negative charge of the remaining LPS inner
section that will facilitate the binding of polycationic peptides.
According to chemical studies performed in B. melitensis, the
core lateral branch contains a mannose and four glucosamines
residues assambled as follows: β-D-GlcpN-(1→ 6)-β-D-GlcpN-
(1 → 4)-[β-D-GlcpN-(1 → 6)]-β-D-GlcpN-(1 → 3)-α-D-
Manp-(1 → 5) (Figure 1). Taking into account that wadC,
wadB, and wadD are perfectly conserved in B. melitensis
and B. abortus, and since WadC adds the mannose (Conde-
Álvarez et al., 2012; Fontana et al., 2016), in all likelihood
the four glucosamines should be added by WadB (Gil-Ramírez
et al., 2014) and WadD. These glucosamines are bound to
each other by β-(1 → 6), or β-(1 → 4) links, and the
one bound to mannose by β-(1 → 3) is also linked to two
glucosamine residues, both in β-(1 → 6) and β-(1 → 4). If
WadB and WadD are the only glycosyltransferases involved
in the assembly of the glucosamine tetrasaccharide and its
binding to the mannose residue, one of them (or both)
could be multi-fiunctional and thus able to add sugars in
different linkage. Most glycosyltransferase enzymes involved
in lipooligosaccharide (LOS) or LPS core biosynthesis are
responsible for one type of sugar addition onto the growing
chain (Raetz and Whitfield, 2002). However, some bacterial
glycosyltransferase enzymes of the GT-2 family, to which WadD
belongs, can be multi-functional and are characterized by the
presence of tandems of two active domains (DXD) on one
polypeptide, as is the case of Lgt3, responsible for the addition
of three glucoses with different linkages [β-(1-3), β-(1-4), and
β-(1-6)] onto the inner core of Moraxella catarrhalis LOS
(Coutinho et al., 2003; Luke-Marshall et al., 2013). Interestingly,
WadD from B. melitensis, B. abortus, and all the orthologs
in the other Brucella spp. conserves two DXD domains,
opening the door to the possibility of a bi-functional role for
this glycosyltransferase (Supplementary Figure S5). This DXD
domain is not present in WadB. Nevertheless, the understanding
of the particular role of each glycosyltransferase in the linkage
of the different glucosamines to form the pentasaccharide
(glucosamine tetrasaccharide bound to mannose) would require
the elucidation of the core chemical structure of wadB and wadD
mutants.
Contrary to most of the genes encoding glycosyltransferases
implicated in the synthesis of the LPS, that are clustered in the
same or related regions of the Brucella genome (Vemulapalli
et al., 2000; Monreal et al., 2003; Rajashekara et al., 2004, 2008;
González et al., 2008), wadC, wadB, and wadD (BAB1_1522,
BAB1_0351, and BAB1_0953, respectively), although all situated
in chromosome I, are isolated and surrounded by other ORFs
apparently not related to LPS synthesis. This, and the fact that
some other genes involved in the synthesis of the core (manBcore
and manCcore) are situated in chromosome II (Monreal et al.,
2003; González et al., 2008), makes even more intriguing the
identification of genes needed for the synthesis of Brucella
core LPS and its lateral branch. Thus, although we think
all glycosyltransferases have been identified, we can not rule
out that other glycosyltransferases could be required for the
assembly of the pentasaccharide that forms the core lateral
branch.
In a chemical characterization of the core LPS previously
performed in a B. melitensis strain different from the one used
in our studies, a glucose residue was found linked to the mannose
that is the depart of the lateral branch, and, if this were the case,
a new glycosyltransferase could be needed (Kubler-Kielb and
Vinogradov, 2013). However, it should be taken into account that
the LPS extraction method and the B. melitensis biovar used for
the determination of the core structure in this experiement were
different from those used in our genetic and biochemical studies
(Figure 1). It is important to notice that the chemical structure we
discuss in Figure 1 has been elucidated in the same B. melitensis
strain where the wadC gene was mutated (Fontana et al., 2016)
and, in this case, no glucose residues were detected. The fact
that, as discussed above, wadC, wadB, and wadD are perfectly
conserved in B. melitensis, reinforces the interpretation of our
results, and the idea that the glycosyltransferases encoded by the
last two genes would be involved in the assembly of glucosamine
residues.
Nevertheless, we should consider that, although the phenotype
of wadC mutant in B. melitensis and B. abortus is similar (Conde-
Álvarez et al., 2012; Fontana et al., 2016), previous results suggest
that there could exist differences in the structure of the core in
these two Brucella spp., since they react differently with MoAbs
against core epitopes (González et al., 2008). Moreover, we have
already seen that some of the studied ORFs (and discarded in
our first screening since they reacted as the parental strain in
the rough and smooth LPS fractions) present differences between
B. abortus and B. melitensis (Supplementary Table S2). Thus, we
could not discard them as the responsible for these differences.
To understand the final role of wadB, wadC, and wadD, it would
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be necessary to analyze and compare the chemical structure of the
core section in mutants in these genes in both spp.
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